In the sub-analysis to evaluate the sensitivity and specificity of HE4 compared with CA125 as a biomarker to discriminate between endometriosis and ovarian cancer, 114 patients were diagnosed with epithelial ovarian cancer and 104 patients were diagnosed with endometriosis. This evidence concerns the gene WFDC2 and ovarian cancer.